Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 31:2018:8953958.
doi: 10.1155/2018/8953958. eCollection 2018.

Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis)

Affiliations

Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis)

E Mazzio et al. Evid Based Complement Alternat Med. .

Abstract

Nerve growth factor (NGF) is an endogenously produced protein with the capacity to induce central nervous system (CNS) neuronal differentiation and repair. NGF signaling involves its binding to tropomyosin-related kinase (Trk) receptors, internalization, and initiation of phosphorylation cascades which cause microtubule reorganization and neuronal outgrowth. Because NGF cannot cross the blood-brain barrier, its therapeutic use is limited. Synthetic peptides that can act as NGF receptor agonists (NGF mimetics) are known to attenuate neurodegenerative pathologies in experimental models of Alzheimer's disease and Parkinson's disease; however, the existence of plant-based NGF mimetics is uncertain. For this reason, we recently completed a high throughput screening of over 1100 nutraceuticals (vitamins, herbal plant parts, polyphenolics, teas, fruits, and vegetables) to identify neuritogenic factor using a PC-12 cell model. Remarkably we found only one, commonly known as the seed of Gac plant (Momordica cochinchinensis) (MCS). In the current study, we further investigated this seed for its neuritogenic effect using bioactivity-guided chemical separations. The data show no biological neuritogenic activity in any chemical solvent fraction, where activity was exclusive to the crude protein. MSC crude proteins were then separated by 1D electrophoresis, where the active neuritogenic activity was confirmed to have a molecular mass of approximately 17 kDa. Subsequently, the 17kDa band was excised, digested, and run on a UPLC-MS/MS with a Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer with data evaluated diverse tools such as X! Tandem, OMS, and K-score algorithms. Proteomic evaluation of the 17kDa band confirmed evidence for 11S globulin subunit beta, napin, oleosin, Momordica trypsin inhibitors (TI) MCoTI-I /II, and many isoforms of Two Inhibitor Peptide Topologies (TIPTOPs). While all peptides identified correspond to the genus/species, Momordica cochinchinensis and Cucumis Sativus, a significant limitation of the analysis is the nonexistence of full annotation for the Momordica cochinchinensis proteome. In conclusion, these findings demonstrate that there is a stable protein within MCS having a mass of 17kDa with the capacity to induce neurite outgrowth. Future work will be required to establish the therapeutic value of the MCS for the treatment of neurodegenerative diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of crude MCS: neurite outgrowth of PC-12 cells at 7 days grown on collagen-coated plates: controls (top), 7S NGF 0.5 µg/mL (mid), and MCS extract (150µg/mL) (bottom). Fluorescent neurite outgrowth imaging using Molecular Probes® Neurite Outgrowth Staining Kit (A, B, C). Morphology (D, E, F) and changes in neurofilament NF-200 kDa obtained by ICC: primary rabbit anti-rat NF-200 kDa, secondary goat anti-rabbit Alexa 488, and nuclear counterstained with propidium iodide in fixed permeabilized cells (G, H, I) with magnified images (J) control (K) MCS seed.
Figure 2
Figure 2
Separations: extraction method 1 (chemical): chemical extractions of MCS seeds were carried out using absolute ethanol, ether, hot ethanol, and ethyl acetate. Solvents were evaporated, reconstituted in ethanol and dilutions prepared in HBSS. Fractionation Schematic Solvent/Protein Extraction Method 2 (protein): Plant Total Protein Extraction Kit PE0230 (Sigma-Aldrich, St. Louis, MO) was used for isolation, and all washes were kept for analysis. All washings as well as the protein isolate were evaporated and diluted in HBSS and evaluated for neuritogenic activity in PC-12 cells. All chemical fractions, methanol, and acetone washes failed to produce neuritogenic effects.
Figure 3
Figure 3
Gel excision layout: total seed proteins (native [A] and reduced) with β-Me [B] were separated using a gradient SDS PAGE gel 4–20% Mini-PROTEAN® TGX™ at 200V for 45 minutes. Gels were stained with Blue-band it®, washed in ultrapure water, then excised and electroeluted back into solution at 200V, reconstituted in HBSS, and evaluated for biological neuritogenic activity on PC-12 cells. All gel sections by process of procedural elimination left only two small biologically active (nonvisual) bands at around 16-17kDa (C45D) containing the predominant neuritogenic active fraction.
Figure 4
Figure 4
Total seed proteins were separated using a gradient gel 8–16% Mini-PROTEAN® TGX™ gel at 200V for 45 minutes. Gels were stained with Blue-band it®, washed in ultrapure water then excised, and electroeluted back into solution at 200V. Samples were reconstituted in HBSS and evaluated for biological activity on PC-12 cells. The 17kDa band contained the main active protein.

Similar articles

Cited by

References

    1. Lindholm D., Mäkelä J., Di Liberto V., et al. Current disease modifying approaches to treat Parkinson's disease. Cellular and Molecular Life Sciences. 2016;73(7):1365–1379. doi: 10.1007/s00018-015-2101-1. - DOI - PMC - PubMed
    1. Garea-Rodríguez E., Eesmaa A., Lindholm P., et al. Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease. PLoS ONE. 2016;11(2) doi: 10.1371/journal.pone.0149776.e0149776 - DOI - PMC - PubMed
    1. Yuan J., Zhang Y., Wang X., Ma H. Exogenous brain-derived neurotrophic factor at a 50 ng/mL concentration has a significant protective effect on bilirubin-induced cerebral cortex neuronal injury. Clinical Laboratory. 2017;63(9):1421–1429. doi: 10.7754/Clin.Lab.2017.170303. - DOI - PubMed
    1. Sharma A. D., Wiederin J., Uz M., et al. Proteomic analysis of mesenchymal to Schwann cell transdifferentiation. Journal of Proteomics. 2017;165:93–101. doi: 10.1016/j.jprot.2017.06.011. - DOI - PubMed
    1. Ebadi M., Bashir R. M., Heidrick M. L., et al. Neurotrophins and their receptors in nerve injury and repair. Neurochemistry International. 1997;30(4-5):347–374. doi: 10.1016/S0197-0186(96)00071-X. - DOI - PubMed

LinkOut - more resources